Novel enterokinase cleavage sequences

Details for Australian Patent Application No. 2001268559 (hide)

Owner Dyax Corp.

Inventors Ladner, Robert Charles; Luneau, Christopher Jon; Ley, Arthur Charles

Agent Davies Collison Cave

Pub. Number AU-B-2001268559

PCT Pub. Number WO01/98366

Priority 60/367345 19.06.00 US

Filing date 19 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 17 March 2005

International Classifications

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 015/10 Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

Event Publications

7 August 2003 Amendment Made

  The nature of the amendment is: Amend priority details from 09/597321 19 June 2000 US to 60/367345 19 Jun 2000 US 2001273387 Gryphon Therapeutics, Inc. The nature of the amendment is: Add co-inventor Jill G. Wilken, remove co-inventors Paolo Botti, Shiah-yun Chen, Sonya Cressman

17 March 2005 Application Accepted

  Published as AU-B-2001268559

14 July 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268560

2001268558